291 related articles for article (PubMed ID: 33177525)
21. Lens induction requires attenuation of ERK signaling by Nf1.
Carbe C; Zhang X
Hum Mol Genet; 2011 Apr; 20(7):1315-23. PubMed ID: 21233129
[TBL] [Abstract][Full Text] [Related]
22. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
[TBL] [Abstract][Full Text] [Related]
23. Mice lacking neurofibromin develop gastric hyperplasia.
Lin L; Chen J; Richardson JA; Parada LF
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G751-61. PubMed ID: 19661150
[TBL] [Abstract][Full Text] [Related]
24. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
25. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.
Wang Y; Kim E; Wang X; Novitch BG; Yoshikawa K; Chang LS; Zhu Y
Cell; 2012 Aug; 150(4):816-30. PubMed ID: 22901811
[TBL] [Abstract][Full Text] [Related]
26. Ras/Raf/ERK signalling and NF1.
Harrisingh MC; Lloyd AC
Cell Cycle; 2004 Oct; 3(10):1255-8. PubMed ID: 15467460
[TBL] [Abstract][Full Text] [Related]
27. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.
Ahmad S; Hughes MA; Johnson GL; Scott JE
J Biomol Screen; 2013 Apr; 18(4):388-99. PubMed ID: 23134735
[TBL] [Abstract][Full Text] [Related]
29. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
30. Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation.
Enomoto A; Fukasawa T; Tsumoto H; Karube M; Nakagawa K; Yoshizaki A; Sato S; Miura Y; Miyagawa K
Sci Rep; 2019 Nov; 9(1):16010. PubMed ID: 31690749
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
32. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
33. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
34. Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.
Rhodes SD; Yang FC
Curr Osteoporos Rep; 2016 Feb; 14(1):10-5. PubMed ID: 26932441
[TBL] [Abstract][Full Text] [Related]
35. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
[TBL] [Abstract][Full Text] [Related]
36. Calcium regulation of EGF-induced ERK5 activation: role of Lad1-MEKK2 interaction.
Yao Z; Yoon S; Kalie E; Raviv Z; Seger R
PLoS One; 2010 Sep; 5(9):e12627. PubMed ID: 20830310
[TBL] [Abstract][Full Text] [Related]
37. Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity.
Huang J; Tu Z; Lee FS
Biochem Biophys Res Commun; 2003 Apr; 303(2):532-40. PubMed ID: 12659851
[TBL] [Abstract][Full Text] [Related]
38. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
39. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.
Yang FC; Chen S; Robling AG; Yu X; Nebesio TD; Yan J; Morgan T; Li X; Yuan J; Hock J; Ingram DA; Clapp DW
J Clin Invest; 2006 Nov; 116(11):2880-91. PubMed ID: 17053831
[TBL] [Abstract][Full Text] [Related]
40. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
